Meeder Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Meeder Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,699	Closed	-$8K	–	2601
2019 Q4	$8K	Buy	1,699 +870	+105%	+$2.75K	﹤0.01%	1658
2019 Q3	$3K	Hold	829	–	–	﹤0.01%	1908
2019 Q2	$3K	Buy	829 +188	+29%	+$770	﹤0.01%	1823
2019 Q1	$3K	Buy	641 +244	+61%	+$853	﹤0.01%	1516
2018 Q4	$1K	Sell	397 -1,011	-72%	-$5.92K	﹤0.01%	1674
2018 Q3	$10K	Buy	1,408 +613	+77%	+$2.68K	﹤0.01%	1174
2018 Q2	$2.94K	Hold	795	–	–	﹤0.01%	1359
2018 Q1	$3K	Hold	795	–	–	﹤0.01%	1343
2017 Q4	$3K	Hold	795	–	–	﹤0.01%	1454
2017 Q3	$3K	Sell	795 -278	-26%	-$1.28K	﹤0.01%	1409
2017 Q2	$5K	Buy	1,073 +522	+95%	+$2.93K	﹤0.01%	1219
2017 Q1	$4K	Sell	551 -763	-58%	-$5.96K	﹤0.01%	1203
2016 Q4	$12K	Buy	+1,314	New	+$11.8K	﹤0.01%	731

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meeder Asset Management's AGTC Position: Q1 2020 in Review

Meeder Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2020, closing a stake of 1,699 shares — an estimated $8K sold.

Meeder Asset Management first reported a position in AGTC in Q4 2016 and held it in 13 quarters. The position peaked at $12K in Q4 2016. 59 funds tracked by Wall St. Rank hold AGTC as of Q1 2020.

Meeder Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2020 after selling out during the quarter.
Meeder Asset Management sold 1,699 Applied Genetic Technologies Corporation shares in Q1 2020, an estimated $8K.
Meeder Asset Management first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 13 quarters.
Meeder Asset Management's Applied Genetic Technologies Corporation position peaked at $12K in Q4 2016.
59 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.